Vanguard Group

Vanguard Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

Vanguard Group’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell
2019 Q3	$1.69M	Buy
2019 Q2	$2.94M	Buy
2019 Q1	$797K	Buy
2018 Q4	$565K	Sell
2018 Q3	$7M	Buy
2018 Q2	$10.8M	Buy
2018 Q1	$6.08M	Buy
2017 Q4	$8.25M	Buy